Chong Kun Dang has entered the cell and gene therapy market in earnest. The drugmaker opened a gene therapy research center on Sept. 27 and unveiled a plan to strengthen open innovation with domestic and foreign companies.The new research center is dubbed "Gen2C," which stands for "Gene to Cure." Th
Daewoong Pharmaceutical announced on Sept. 28 that its botulinum toxin ABP-450 (Korean product name: Nabota) has proved effective for treating cervical dystonia in U.S. phase 2 clinical trials.The company unveiled the topline results of the clinical trials, which have been carried out by AEON Biopha
SK Group announced on Sept. 26 that it offered free surgery for Vietnamese children with facial deformities at 108 Military Central Hospital in Hanoi from Sept. 19 to 23, in cooperation with Seoul National University Bundang Hospital and Smile for Children, a Korean medical volunteer organization. T
Korea Ginseng Corp. (KGC) will launch a child nutrition support project in Vietnam together with World Vision, an international relief and development NGO, through the “Hongyi! Help Us!” Season 3 campaign.Vietnam’s Huong Hoa and Dak Glong Districts, the main target regions of the campaign, are among
EOFlow Co., a provider of wearable drug delivery solutions, announced on Sept. 23 that its European exclusive distributing partner A. Menarini Diagnostics showcased its tubeless, wearable, and disposable insulin pump “EOPatch” at the annual meeting of the European Association for the Study of Diabet
Spectrum Pharmaceuticals, a U.S. biopharmaceutical company that has licensed poziotinib from Korea's Hanmi Pharmaceutical, announced on Sept. 22 that the U.S. Food and Drug Administration’s (“FDA”) Oncologic Drugs Advisory Committee (“ODAC”) met to review poziotinib for the treatment of patients
Coupang’s logistics subsidiary Coupang Fulfillment Service (CFS) has appointed Ryan Brown, vice president of environment, health and safety at Coupang, as its CEO of environment, health and safety.CFS now has four CEOs, including Um Sung-hwan, CEO of human resources, Jeong Jong-cheol, CEO of legal a
Lotte Chilsung Beverage announced on Sept. 19 that it exported more than 10 million cans (250 ml) of milky soda Milkis to Taiwan from January to August 2022.The Korean beverage giant began to export Milkis to Taiwan in the second half of 2020. Exports in the first eight months of 2022 soared about 8
Global liquor company Pernod Ricard Korea announced on Sept. 20 that it will hold an ‘Accor Bar Exchange’ promotion with global hotels affiliated with the ‘Accor’ hotel chain.The ‘Accor Bar Exchange’ promotion will showcase the talents and creativity of Accor Hotel bartenders and will be held at Fai
Amorepacific’s Laneige brand announced on Sept. 14 that its products debuted in the Japanese market through Atocosme Online and Atocosme's Harajuku branch in Tokyo on Sept. 14.Atocosme (@cosme) is Japan’s largest review-based beauty care information platform. Recently, it has opened an experient
The Financial Supervisory Service announced on Sept. 18 that Nike Korea’s sales increased 15 percent year on year to 1.6749 trillion won in its 2022 fiscal year (June 1, 2021 to May 31, 2022), in which its operating profit increased 230 percent to 95.9 billion won and its net profit increased from l
Dong-A ST announced on Sept. 15 that it has signed a global license-out and equity investment contract with NeuroBo Pharmaceuticals of the United States on Sept. 14.Dong-A ST has licensed out DA-1241, a treatment for type 2 diabetes and nonalcoholic steatohepatitis, and DA-1726, a treatment for obes
NESTYLE, Inc. has launched Collery, an artificial intelligence (AI)-based content creation platform for single creators. Since most types of content are created by single creators, the company launches Collery to help them spread their content through the platform.NESTYLE is a startup established by
Hanmi Pharmaceutical has obtained U.S. approval for its neutropenia treatment Rolontis, opening a new chapter in its R&D history. It is the first drug that Hanmi has succeeded in commercializing in the global market.Spectrum Pharmaceuticals, a U.S. partner to which Hanmi Pharmaceutical licensed out
Chong Kun Dang announced on Sept. 13 that it shared the results of the Phase 1 clinical trial on CKD-702, a new anticancer dual antibody biotech drug, at the European Society for Medical Oncology (ESMO) annual conference held in Paris, France from Sept. 9 to 13.Since May 2020, Chong Kun Dang has bee
U.S. President Joe Biden signed an executive order on Sept. 12 to launch the National Biotechnology and Biomanufacturing Initiative, which is for boosting production in the U.S. pharmaceutical and biotech sectors. The idea is to build new supply chains and create decent jobs in the sectors to rely l
Pernod Ricard Korea announced on Sept. 14 the launch of three 'KINOBI Gins,’ premium gins inspired by the nature and traditions of Kyoto, Japan.The gins are crafted in Kyoto, a Japanese city with a blessed natural environment. Cultural capital for over a thousand years, Kyoto embodies the quinte
Multiple foreign pharmaceutical companies in South Korea are receiving voluntary retirement applications. Although they are mentioning HQ reorganization as their reason, employees are claiming that the companies are undermining employment stability despite stable business figures.Novartis Korea rece
Coway Co. has received esteemed awards for the NOBLE range’s design excellence at the International Design Excellence Awards (IDEA) 2022, the company announced on Sept. 13.Hosted annually by the Industrial Designers Society of America (IDSA), IDEA is one of the most influential design awards program
Kolmar Korea will develop and supply private brand (PB) cosmetics to the United Arab Emirates Business Point Consultancy (UAE BPC), a government-backed trade and business institution in the UAE.The company announced on Sept. 7 that UAE BPC chairman Abdullah Al Maini, UAE BPC CEO Ahmed Al Ali, and In